Ekso Bionics Holdings Inc (EKSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,169 | 2,722 | 5,242 | 8,054 | 6,493 |
| Receivables | 7,308 | 6,048 | 4,533 | 6,457 | 7,238 |
| Inventories | 4,822 | 5,023 | 5,439 | 4,962 | 4,571 |
| TOTAL | $14,049 | $14,796 | $15,974 | $20,068 | $18,843 |
| Non-Current Assets | |||||
| PPE Net | 1,288 | 1,237 | 1,435 | 1,450 | 1,577 |
| Intangibles | 3,931 | 4,583 | 4,666 | 4,748 | 5,011 |
| Other Non-Current Assets | 843 | 1,045 | 1,092 | 1,044 | 1,221 |
| TOTAL | $6,062 | $6,865 | $7,193 | $7,242 | $7,809 |
| Total Assets | $20,111 | $21,661 | $23,167 | $27,310 | $26,652 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,008 | 1,937 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,431 | 1,661 | 1,448 | 1,999 | 1,552 |
| Accrued Expenses | 1,779 | 1,930 | 1,760 | 2,966 | 2,352 |
| TOTAL | $8,636 | $8,939 | $6,714 | $8,553 | $7,537 |
| Non-Current Liabilities | |||||
| Long Term Debt | 798 | 1,070 | 3,335 | 3,597 | 3,854 |
| Deferred Revenues | 1,727 | 1,700 | 1,808 | 1,913 | 1,956 |
| Other Non-Current Liabilities | 236 | 342 | 499 | 509 | 634 |
| TOTAL | $2,448 | $3,043 | $5,523 | $6,065 | $6,408 |
| Total Liabilities | $11,084 | $11,982 | $12,237 | $14,618 | $13,945 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,563 | 2,623 | 2,612 | 1,937 | 1,656 |
| Common Shares | 37 | 36 | 36 | 28 | 22 |
| Retained earnings | -262,396 | -257,722 | -256,301 | -253,592 | -250,475 |
| Other shareholders' equity | -692 | -700 | -683 | 424 | 957 |
| TOTAL | $9,027 | $9,679 | $10,930 | $12,692 | $12,707 |
| Total Liabilities And Equity | $20,111 | $21,661 | $23,167 | $27,310 | $26,652 |